From Diagnosis to Remission: A Brave Journey Through Gallbladder Cancer Treatment
- JRX Global
- May 11
- 2 min read
"I’m feeling amazing and getting stronger every day! It’s been an incredible journey, and I’m so grateful for the support and care I’ve received. I started doing my daily activities again, and just last Saturday, I completed a hike—something I thought would be impossible a few months ago! Although I still experience some joint pain and have to visit the restroom more frequently, the progress I’ve made is nothing short of miraculous. ECCT has truly made a difference in my life, and I’m thrilled to be back to being active!"
— Ms. Usha, Malaysia
"My sister’s transformation has been nothing short of extraordinary. When we first came to you, we were desperate for hope, and what you’ve given us is beyond what I could have ever imagined. Today, my sister is doing yoga, working out at the gym with a personal trainer, and has become even stronger than I am! Thank you for giving her the strength to thrive again. We are forever grateful."
— Usha's Sister
Her Journey of Gallbladder Cancer Treatment and Progress:
June 2023: Diagnosis of gallbladder cancer with liver metastases.
July 18, 2023 (PET CT): Multiple liver metastases (largest 64 mm), hypermetabolic abdominal and para-aortic nodes, and left supraclavicular nodes involved. Chemotherapy with Gemcitabine, Cisplatin, and Durvalumab initiated. Abdominal nodal metastases resolved.
Nov 2023: Completed chemotherapy
December 2023: MRI showed one lesion in the liver, but TACE wasn’t possible. Open surgery, cholecystectomy, and resection of 10% of the liver.
August 9, 2024 (PET CT): New mediastinal nodes and bilateral pleural effusions (suspected to cause by flu and bad cough).
September 1, 2024: Started ECCT.
September 18, 2024 (PET CT): Resolution of mediastinal and hilar nodes, and thyroid hypermetabolism reduced.
May 6, 2025 PET CT): The scan shows no conclusive evidence of recurrent, regional, or distant metastatic disease, with decreased thyroid FDG uptake likely benign and stomach FDG uptake likely due to gastritis.
This inspiring story is a testament to the power of continued treatment, hope, and determination to win the disease. Ms Usha disease remain at remission state as of 11 May 2025. She hopes all cancer warrior out there to not give up and always try and stay positive.
Comments